CSIMarket
 


Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Revenue Growth by Quarter and Year

Abbott Laboratories's Revenue results by quarter and year




ABT Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 10,241.00 10,091.00 11,468.00
III Quarter September 10,635.00 10,143.00 10,410.00 10,928.00
II Quarter June 10,377.00 9,978.00 11,257.00 10,223.00
I Quarter March 9,964.00 9,747.00 11,895.00 10,456.00
FY   30,976.00 40,109.00 43,653.00 43,075.00



ABT Revenue third quarter 2024 Y/Y Growth Comment
Abbott Laboratories reported Revenue growth of 4.85% year on year in the third quarter 2024, to $ 10,635.00 millions, this is lower than Abbott Laboratories's recent average Revenue growth of 5.29%.

Looking into third quarter 2024 results within Major Pharmaceutical Preparations industry 56 other companies have achieved higher Revenue growth. While Abbott Laboratories' s Revenue increase of 4.85% ranks overall at the positon no. 886 in the third quarter 2024.




ABT Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 1.49 % -12.01 % 7.17 %
III Quarter September 4.85 % -2.56 % -4.74 % 23.44 %
II Quarter June 4 % -11.36 % 10.11 % 39.51 %
I Quarter March 2.23 % -18.06 % 13.76 % 35.34 %
FY   - -8.12 % 1.34 % 24.47 %

Financial Statements
Abbott Laboratories's third quarter 2024 Revenue $ 10,635.00 millions ABT's Income Statement
Abbott Laboratories's third quarter 2023 Revenue $ 10,143.00 millions Quarterly ABT's Income Statement


ABT Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 0.97 % -3.06 % 4.94 %
III Quarter September 2.49 % 1.65 % -7.52 % 6.9 %
II Quarter June 4.14 % 2.37 % -5.36 % -2.23 %
I Quarter March -2.7 % -3.41 % 3.72 % -2.29 %
FY (Year on Year)   - -8.12 % 1.34 % 24.47 %




Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #57
Healthcare Sector #153
Overall #886

Revenue Y/Y Growth Statistics
High Average Low
42.3 % 5.29 % -47.82 %
(Dec 31 2017)   (Dec 31 2013)
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #57
Healthcare Sector #153
Overall #886
Revenue Y/Y Growth Statistics
High Average Low
42.3 % 5.29 % -47.82 %
(Dec 31 2017)   (Dec 31 2013)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Abbott Laboratories's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
85.61 % 1.87 % -50.37 %
(June 30. 2012)  


ABT's III. Quarter Q/Q Revenue Comment
Abbott Laboratories achieved in the III. Quarter 2024 above company average sequential Revenue growth of 2.49%, to $ 10,635.00 millions, from $10,377.00 millions in the second quarter.

Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 339.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #32
Overall #339
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #32
Overall #339
Revenue Q/Q Growth Statistics
High Average Low
85.61 % 1.87 % -50.37 %
(June 30. 2012)  


ABT's III. Quarter Q/Q Revenue Comment
Abbott Laboratories achieved in the III. Quarter 2024 above company average sequential Revenue growth of 2.49%, to $ 10,635.00 millions, from $10,377.00 millions in the second quarter.

Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 339.


Abbott Laboratories's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 41,217.00 $ 40,725.00 $ 40,326.00 $ 40,109.00 $ 39,959.00
Y / Y Revenue Growth (TTM) 3.15 % 1.24 % -2.84 % -8.12 % -11.26 %
Year on Year Revenue Growth Overall Ranking # 757 # 832 # 1556 # 1171 # 664
Seqeuential Revenue Change (TTM) 1.21 % 0.99 % 0.54 % 0.38 % -0.66 %
Seq. Revenue Growth (TTM) Overall Ranking # 568 # 1894 # 780 # 1390 # 643


Cumulative Revenue growth Comment
Although Abbott Laboratories's Annual Revenue growth year on year were below company's average 5.01% , Revenue announced in the Sep 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.15% year on year, from 1.24% in Jun 30 2024.

In the Healthcare sector 75 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 757, from total ranking in previous quarter at 832.

Revenue TTM Q/Q Growth Statistics
High Average Low
31.35 %
5.01 %
-39.34 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 76
Overall # 757

Revenue TTM Y/Y Growth Statistics
High Average Low
31.35 %
5.01 %
-39.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 67
S&P 500 # 568
Cumulative Revenue growth Comment
Although Abbott Laboratories's Annual Revenue growth year on year were below company's average 5.01% , Revenue announced in the Sep 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.15% year on year, from 1.24% in Jun 30 2024.

In the Healthcare sector 75 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 757, from total ranking in previous quarter at 832.

Revenue TTM Q/Q Growth Statistics
High Average Low
31.35 %
5.01 %
-39.34 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 76
Overall # 757

Revenue TTM Y/Y Growth Statistics
High Average Low
31.35 %
5.01 %
-39.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 67
S&P 500 # 568




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ABT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ABT's Competitors
Revenue Growth for Abbott Laboratories's Suppliers
Revenue Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
Bristol myers Squibb Company8.44%$ 8.444 millions
Quest Diagnostics Inc8.41%$ 8.410 millions
Siga Technologies Inc8.39%$ 8.388 millions
Sotera Health Company8.38%$ 8.381 millions
Medpace Holdings Inc 8.29%$ 8.288 millions
Tango Therapeutics Inc 8.15%$ 8.153 millions
Hca Healthcare Inc 7.86%$ 7.858 millions
Merit Medical Systems Inc7.72%$ 7.721 millions
Karyopharm Therapeutics Inc 7.70%$ 7.704 millions
Chemed Corporation7.38%$ 7.378 millions
Labcorp Holdings Inc 7.37%$ 7.367 millions
Addus Homecare Corporation7.22%$ 7.220 millions
Ati Physical Therapy Inc 7.06%$ 7.062 millions
Merus N v 6.70%$ 6.698 millions
Idexx Laboratories Inc6.56%$ 6.564 millions
Integer Holdings Corporation6.43%$ 6.430 millions
Amphastar Pharmaceuticals Inc 5.90%$ 5.903 millions
Carlisle Companies Incorporated5.86%$ 5.858 millions
Select Medical Holdings Corp5.73%$ 5.735 millions
Amedisys Inc5.65%$ 5.651 millions
Revance Therapeutics Inc 5.47%$ 5.465 millions
Masimo Corp5.30%$ 5.305 millions
Royalty Pharma Plc5.29%$ 5.291 millions
Enzon Pharmaceuticals inc 5.14%$ 5.145 millions
Owens and Minor inc 4.99%$ 4.986 millions
Privia Health Group Inc 4.95%$ 4.946 millions
Tactile Systems Technology Inc 4.94%$ 4.942 millions
Abbott Laboratories4.85%$ 4.851 millions
Bio techne Corp4.64%$ 4.644 millions
Davita Inc 4.56%$ 4.558 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com